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Abstract. The integrin av[36 is only expressed in epi- 
thelial cells. In healthy adult epithelia, this receptor is 
barely detectable, but expression is rapidly induced fol- 
lowing epithelial injury. Mice homozygous for a null 
mutation in the gene encoding the 1~6 subunit had juve- 
nile baldness associated with infiltration  of macro- 
phages into the skin, and accumulated activated lym- 
phocytes around conducting airways in the lungs. 136 -/- 
mice also demonstrated airway hyperresponsiveness to 
acetylcholine, a hallmark feature of asthma. These re- 
suits suggest that the epithelial integrin av136 partici- 
pates in the modulation of epithelial inflammation.  Ge- 
netic or acquired alterations in this integrin could thus 
contribute to the development of inflammatory dis- 
eases of epithelial organs, such as the lungs and skin. 
I 
NTEGRINS are heterodimeric receptors for extracetlular 
matrix  and  cell surface  ligands  that  have  been  sug- 
gested  to  play  important  roles  in  development,  in- 
flammation,  wound  healing,  and  tumorigenesis  (Hynes, 
1987, 1992;  Ruoslahti  and  Pierschbacher,  1987).  In vitro, 
integrins  have been shown to contribute to cell adhesion, 
spreading  and migration,  and to more complex processes 
including cell proliferation,  apoptosis, and the regulation 
of  gene  expression  (Hynes,  1992;  Juliano  and  Haskill, 
1993). In vivo, the biological importance  of integrins  has 
been most clearly demonstrated  for control  of leukocyte 
migration and platelet aggregation. At least some integrins 
play critical roles in development, as demonstrated by the 
findings  that  the  inactivation  of the  genes encoding  two 
different integrin ~ subunits, a4 (Yang et al., 1995) and ~5 
(Yang et al., 1993), are embryonic lethal mutations.  How- 
ever, although epithelial cells express several different in- 
tegrins, the roles epithelial integrins play in health and dis- 
ease remain largely unknown. 
The integrin  [36 subunit is expressed exclusively in epi- 
thelial  cells,  and  only  in  a  single  integrin  heterodimer, 
av[36,  a  receptor for the  extracellular  matrix  proteins  fi- 
bronectin  (Busk et al., 1992;  Weinacker  et al.,  1994) and 
tenascin  (Prieto et al.,  1993). av[36  is highly expressed in 
the lung, skin, and kidney during organogenesis (Breuss et 
al., 1995). In epithelia of healthy adults, this receptor is ex- 
pressed  at  very low levels,  except  in  the  endometrium, 
where av[36 is highly expressed during the secretory phase 
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of the menstrual cycle, and in the lung and kidney, where 
cw136 is often expressed in a patchy distribution associated 
with subclinical inflammation (Breuss et al., 1995). av[36 is 
highly  expressed  in  response  to  injury  or inflammation, 
and in malignant epithelial neoplasms (Breuss et al., 1995). 
For example, in experimental skin wounds, av136 is highly 
expressed in the keratinocytes at the wound edge within a 
few days of wounding,  where it remains  expressed until 
soon after wound closure is complete.  In the respiratory 
epithelium, av136 mRNA expression is induced within 5 h 
of acute injury, and c~v136 protein can be detected in the 
epithelium of patients with a variety of inflammatory lung 
diseases  (Breuss  et  al.,  1995;  Weinacker  et  al.,  1995). 
These findings  suggest a role for this receptor in the re- 
sponse of epithelia to injury. 
To examine the role(s) that cxv[36 plays in vivo, we have 
generated  mice lacking  136 expression  using homologous 
recombination  in  embryonic  stem  cells.  These  mice  de- 
velop  and  reproduce  normally,  but  develop functionally 
significant infiltration  of their skin and lungs with inflam- 
matory cells. In the conducting airways of the lung, these 
morphologic changes are associated with enhanced bron- 
choconstrictor  sensitivity  to  acetylcholine,  the  central 
physiologic abnormality in human asthma. 
Materials and Methods 
Inactivation  of the f16 Subunit Gene in Mouse 
Embryonic Stem Cells 
We initially amplified a  240-bp fragment of mouse [36 cDNA by poly- 
merase chain reaction  (PCR)  with  degenerate  mixtures of oligonucle- 
otides based on the human and guinea pig 136 sequences (Sheppard et al., 
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mouse 129 strain library, and obtained a 15-kb clone containing two exons 
and portions of three large introns. The most 5' exon extended to within 
50 amino acids of the predicted 5' end of the mature protein, predicted on 
the basis of the human sequence. We used a 7-kb EcoRI fragment of this 
clone to construct a replacement vector that contained a neomycin resis- 
tance gene inserted into the second of the two exons in our clone, and a 
thymidine kinase gene at the 5' end (see Fig. 1). We introduced this vector 
into 129 strain mouse embryonic stem (ES) I cells and identified targeted 
clones by Southern blotting with two different probes and by PCR. The 
ES cell line used, RF8, was derived from agouti 129/terSV  mice (a gift 
from Dennis Huszar, GenPharm International, Mountain View, CA) and 
cultured on SNL76/7 mitotically inactive feeder cells (a gift from Allan 
Bradley, Baylor College of Medicine, Houston, TX). Only targeted clones 
resulting from a single integration event (as judged by Southern blotting 
using a neo probe) were used for blastocyst injection. Targeted clones were 
injected into C57B1/6  blastocysts, and one of these clones produced two 
90%  chimeric  male  offspring  that  transmitted  the  inactivated  gene 
through the germline, as determined by both Southern blotting and PCR. 
Heterozygous offspring of crosses between these high percentage chimeras 
and pure C57B1/6 females were crossed to produce mice that were ho- 
mozygous for the null mutation, and homozygous wild-type litter mates 
that served as controls in subsequent experiments. The 240-bp fragment 
used for library screening was originally amplified by PCR with 13 subunit 
primers  B1AF  (5'-CCIA(G)TIGAC(T)C(AT)TTAC(T)T(A)T(A)IC- 
(T)TIATGGA  -3')  and  B2AR  (5'-GGICTT(C)CCACCIA(G)AICTA- 
(G)CGG(T)TAITACG-3'). The resultant fragment was reamplified with 
degenerate  136  primers  1363F (5'-GA(TC)GA(TC)CTIAA(CT)ACIAT- 
(CAT)AA(GA)GA-3')  and  1364R  (5'-TC(GA)TI'(GA)AA(CT)CT(CT)- 
TCIGC(GA)TC(GA)Tr-3') designed based on human and guinea pig 136 
sequences (Sheppard et al., 1990). 
Detection of  Recombinant Clones by PCR and 
Southern Blot 
RF8 embryonic stem cells were grown in embryonic stem cell complete 
media. The targeting vector was linearized at a unique SacII site and trans- 
fected into RF8 ES cells by electroporation. Selection medium containing 
the neomycin analogue G418 (0.15 mg/ml) and FIAU (0.2 p.m) was used to 
obtain resistant clones. Individual colonies were screened by PCR and South- 
ern blotting. PCR was performed with a forward primer from within the 
introduced neomycin resistance gene (neoF-5'CAGTAAATCGTTGTC- 
AACAG) and a reverse primer from the mouse 136 gene 3' of the target- 
ing vector (Km136R-5'GTGGATCTGCTAAGTI'AACC). For Southern 
blotting, genomic DNA digested with BamHI was blotted with two differ- 
ent probes, one specific for mouse 136 and the other for the inserted neo- 
mycin resistance gene, and only clones with a single integration were used 
for blastocyst injection. 
Generation of Germline Chimeras 
Chimeras were generated as described by Bradley (1987).  ES cells were 
injected  into C57B1/6  blastocysts and the injected  embryos were  trans- 
ferred into the uteri of pseudopregnant recipients. Chimeras identified by 
the presence of an agouti coat color were test-mated with C57Bl/6J fe- 
males. Offspring were tested for the targeted 136 gene by PCR and South- 
ern blotting. 
Keratinocyte Culture and Immunoprecipitation 
Mouse skin was removed and placed in 0.1% protease (Sigma Chem. Co., 
St.  Louis, MO) at 4°C overnight. The following day the skin was trans- 
ferred to 0.05% trypsin and the epithelial layer was scraped off with a sur- 
gical blade. After 30 min incubation in trypsin, cells were disaggregated by 
pipetting, and passed through a  150-~m nylon mesh to remove residual 
hair. The cells were suspended in keratinocyte growth medium (Clonetics, 
San Diego, CA), plated onto dishes coated with collagen, and grown to 
confluence. After overnight labeling with [35S]methionine, cells were lysed 
in immunoprecipitation buffer (100 mM Tris-HC1, pH 7.5, 0.1% SDS, 1% 
Triton X-100, 0.1% NP-40, 300 mM NaC1) and immunoprecipitated with 
Ab 206 which was raised against the cytoplasmic domain of human 136. 
1. Abbreviations  used in this paper: ES, embryonic stem; IL-4, interleukin-4; 
RL, pulmonary resistance. 
Samples were analyzed by SDS-PAGE on 7.5% acrylamide gels and ex- 
posed to film at -80°C. 
Reverse Transcriptase-PCR 
Total RNA was harvested from lung and kidney tissue using Trizol re- 
agent (BRL, Grand Island, NY) and cDNA was synthesized using Su- 
perscript  reverse  transcriptase (BRL).  A  360-bp fragment of murine 136 
flanking the neomycin resistance gene insertion site using primers m1366F 
(5' CAGTrCTGACATTGTTCAGA 3') and m1365R (5' TGTTAATGG- 
CAAAATGTGCT 3'). 
Collection of  Lung Cells and Flow Cytometry 
Mouse lungs were perfused with PBS via the main pulmonary artery to re- 
move intravascular cells. The lungs were removed and minced into fine 
fragments that were gently dispersed into RPMI medium (GIBCO BRL) 
using a syringe plunger and passed through a 0.75-tLm nylon mesh filter. 
Cells from minced mouse lungs were stained with phycoerythrin-, fluores- 
cein isothiocyanate-, or biotin-conjugated antibodies against CD4, CD8, 
B220, and CD25 (Caltag, South San Francisco, CA) and analyzed for surface 
expression using a FACSCAN flow cytometer (Becton Dickinson, Moun- 
tain View, CA). 
Histology and Immunohistochemistry 
Freshly isolated organs were embedded in OCT and quick frozen in liquid 
nitrogen.  Serial  5-~m sections were  prepared  and fixed in Histochoice 
(Fisher Scientific, Pittsburgh, PA) for hematoxylin and eosin staining. For 
immunohistochemistry,  frozen sections were fixed in cold acetone for 5-10 
rain and air-dried. Sections were blocked for endogenous peroxidase and 
biotin activities with Peroxoblock solution (Zymed Labs, S. San Francisco, 
CA) and Avidin/Biotin Blocking Kit (Vector Labs, Inc., Burlingame, CA) 
at  room temperature.  After rinsing, sections were  blocked  with 0.25% 
casein/0.025% thimerosal in PBS for 15 min and then incubated overnight 
at 4°C in biotin-labeled primary antibodies against CD3 (T cells), B220 (B 
cells), and F4/80 (macrophages) (all from Caltag). After washing, sections 
were  incubated in ABC avidin/peroxidase reagent  (Vector)  for  1 h  at 
room temperature. Chromagen was developed using the DAB Plus Kit 
(Zymed). Finally, sections were dehydrated and mounted with permount 
onto clean slides. 
Measurement of  Airway Resistance 
Mice were anesthetized with pentobarbital (50 mg/kg, i.p.), the chest was 
opened, and a tracheotomy tube was inserted. The mice were paralyzed 
with pancuronium bromide (0.1  mg/kg), and then ventilated with 100% 
oxygen by a  Harvard  small animal ventilator at  a  rate  of 150  breaths/ 
minute and a tidal volume of 9 I~l/gm. In pilot experiments, we determined 
that these settings result in near normal values of arterial (left ventricular) 
pH and pCO  2. A  heparinized, indwelling catheter was placed in the tail 
vein, and the animal was placed in an airtight plexiglass plethysmograph, 
with the venous catheter threaded through a small hole in the plethysmo- 
graph. Airway pressure and plethysmograph pressure were continuously 
measured by differential pressure transducers and recorded on a Hewlett- 
Packard chart recorder.  Pulmonary resistance (RL), tidal volume, flow, 
and dynamic lung compliance were continuously calculated by a  Buxco 
Pulmonary  Mechanics  analyzer.  RL  was  calculated  on  each  inspired 
breath as the ratio of driving pressure to airflow at 70% of inspired tidal 
volume.  Increasing concentrations  of acetylcholine  were  administered 
through the tail vein catheter at 2-min intervals, and peak pulmonary re- 
sistance in response to each concentration was determined. 
Elispot Assay 
Elispot assay were performed as described (Corry et ak, 1996). This assay 
is a modification of a sandwich ELISA that allows the identification of in- 
dividual cells that are secreting specific antigens. Briefly, wells of 96-well 
microtiter plates (Dynatech, Chantilly, VA) were coated with either mAb 
against IFN-7  (R46A2)  or  IL-4  (BVD4-1Dll.2)  at  4°C  overnight and 
blocked with 10% FBS. Pooled cells from minced lungs were plated and 
incubated at 37°C overnight. Plates were incubated for I  h with biotiny- 
luted secondary antibodies XMG-1.2 to IFN-7 and BVD6-24G.2 to IL-4, 
and then with streptavidin-conjugated alkaline phosphatase (Jackson Im- 
munoResearch, West Grove, PA) for another hour. Between incubations, 
plates were  washed with phosphate buffered saline supplemented with 
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plates with 5-bromo-4-chloro-3-indolyl  phosphate (Sigma) in 2-amino-2- 
methyl-l-propanol buffer (Sigma) suspended in 0.6% agarose low-melt 
gel. After solidification of the agarose, individual blue spots were counted 
under an inverted microscope. 
Results 
Mice Homozygous for a Null Mutation in the ~6 
Subunit Develop Juvenile Baldness 
To  assess  whether  /36 -/-  mice  produced  [36  mRNA,  we 
amplified  cDNA  obtained  from the  lung  and  kidney  of 
/36 -/- and/36 +/+ mice by PCR using oligonucleotide prim- 
ers  flanking  the  exon  disrupted  by  our  targeting  vector 
(Fig. 1). The expected 360-bp fragment could be amplified 
from the cDNA of/36  +/+ mice, but no amplification prod- 
uct was detectable from the cDNA of/36  -/- mice (Fig. 2 A). 
To confirm that/36 -/- mice were not capable of making [36 
protein, we attempted to immunoprecipitate 136 from met- 
abolically labeled lysates of cultured keratinocytes with an 
antibody raised against a peptide based on the cytoplasmic 
domain  sequence  of  human  136  (Ab  206  [Busk  et  al., 
1992]).  The  anti-J36  antibody  immunoprecipitated  two 
bands of the appropriate apparent molecular masses to be 
av and  136, from/36 +/+  keratinocytes,  but no bands  were 
immunoprecipitated from/36 -/- keratinocytes (Fig. 2 B). 
Mice homozygous for the null mutation were born at ap- 
proximately the expected Mendelian frequency from het- 
erozygous intercrosses (30%  +/+, 48%  +/-,  and 22%  -/- 
of 234 offspring analyzed), demonstrating that this integrin 
subunit, in contrast to a4 (Yang et al., 1995) and a5 (Yang 
et al.,  1993), is not absolutely required  for embryonic de- 
velopment.  However,  /36 -/-  mice  were  not  completely 
normal.  All  /36  -/-  mice  failed  to  develop  hair  normally 
over the tops of their heads, the backs of their necks, and 
the inner surface of their  thighs  (Fig.  3 A). These  abnor- 
malities  were  visually  apparent  by postnatal  day  5,  and 
persisted  through day 20-30.  After this time, hair growth 
resumed over the head and neck but remained sparse over 
the inner surface of the thighs. No gross abnormalities  in 
Figure 2.  (A) RT-PCR analysis  of mRNA from/36  +/+ and/36  -/- 
mice. Total RNA was extracted from mouse lung and kidney and 
transcribed to complementary DNA (cDNA). A 360-bp amplifi- 
cation fragment was detectable in tissues of/36  +/+ mice but not of 
/36  -/- mice with primers specific for wild-type 136 cDNA. (B) Im- 
munoprecipitation  of av136. Primary  cultures  of keratinocytes 
from/36  +/+ and/36 -/- were labeled overnight with  [3SS]methio- 
nine  and  cell  lysates  were  immunoprecipitated  with  Ab  206, 
raised against the human [36 cytoplasmic domain. Immunoprecip- 
itated proteins were analyzed by 7.5% SDS-PAGE under nonre- 
ducing conditions. The positions of molecular size markers  (in 
kD) are shown to the left. 
any other organs have been apparent in mice followed for 
up to 6  mo. Furthermore,/36 -/- mice gained weight nor- 
mally and were fertile. 
The Dermis in Bald Areas of f16  -/- Mice Is Infiltrated 
with Macrophages 
The hair loss seen in/36 -/- mice was associated with mor- 
phologic abnormalities  in the dermis of affected areas. In 
comparison to/36 +/+ mice, 136  -/- mice had fewer hair folli- 
cles, and numerous degenerating hair follicles surrounded 
by foci of mononuclear cells (Fig. 3 C). The mononuclear 
cells  resembled  tissue  macrophages  and  stained  with  the 
monocyte/macrophage marker F4/80. Furthermore,  stain- 
ing with F4/80 demonstrated increased numbers of mono- 
cytes/macrophages throughout the dermis of the bald ar- 
eas  in  /36  -/-  mice  (Fig.  3  E).  Staining  with  antibodies 
specific for mouse T  cells and B  cells did not demonstrate 
Figure  1.  (A)  Replacement 
vector for  inactivation  of the 
136  gene  in  mouse  embryonic 
stem  (ES)  cells.  Top  panel 
shows the structure of a 15-kb 
fragment of the mouse 136 gene 
isolated  from a  129 strain  ge- 
nomic library.  The two exons 
in this  fragment are shown as 
solid  boxes.  Middle  panel 
shows  the  targeting  plasmid 
constructed  in  pBluescript 
(Stratagene, La Jolla, CA) and 
linearized  at  a  unique  SacII 
site. A neomycin-resistance gene under the control of the RNA polymerase II promoter (neo) and herpes simplex virus thymidine ki- 
nase (HSV-tk) gene (gifts from Kirk Thomas, University of Utah, Salt Lake City, UT) are shown as shaded boxes. Bottom panel shows 
the expected structure of the [36 gene after homologous recombination. The arrowheads represent PCR primers used to identify homol- 
ogous recombination events in ES cell colonies. The forward primer is located in the neo gene and the reverse primer is 3' of the target- 
ing vector. These primers generated a 1.2-kb fragment in targeted clones. The locations of the two probes used for Southern blotting are 
shown as lines. Hybridization of either probe with genomic DNA digested with BamHI yielded a new 6.8-kb band in targeted clones. 
(B) Southern blot analysis of wild-type (first two lanes) and targeted (last two lanes) ES clones digested with BamHI and hybridized with 
the external probe (probe 2). 
Huang et al. Integrin ~6 Subunit Knockout  923 Figure 3.  (A) Photograph of a f16  -/- mouse (left) and a t36  +/+ littermate (right) at 10 d of age. In contrast to the/36 +/+ mouse, the 136  -j- 
mouse demonstrates the typical pattern of juvenile baldness over the head and neck. 136 -/- mice also lack hair over the inside  of their 
thighs. B and C are low power photomicrographs of sections of frozen inner thigh skin from a/36  +/+ (B) and a/36  -/- mouse (C) stained 
with hematoxylin and eosin (H and E), and demonstrate loss of hair follicles and infiltration of the dermis in the/36 -/- animal.  D and E 
are higher power photomicrographs of frozen sections of skin from the same areas of the same 136  +/+ (D) or 136  -/- mouse (E) stained 
with the monocyte/macrophage marker F4180, and lightly counterstained with H and E. Hair follicles are marked with arrows.  Infiltrat- 
ing macrophages are marked with arrowheads. Note the marked increase in F4/80 positive cells in the/36 -/- mouse. 
any increase  in lymphocytes in the skin lesions  (data not 
shown). No morphologic abnormalities  were seen in skin 
taken from unaffected areas. 
Expression of av136 is induced within a few days of cuta- 
neous wounding, is expressed only in the keratinocytes at 
the wound edge, and remains expressed until wounds are 
completely closed  (Breuss  et  al.,  1995).  The  two  known 
ligands for etv136, fibronectin (Busk et al., 1992; Weinacker 
et al., 1994), and tenascin (Prieto et al., 1993), are compo- 
nents of the provisional matrix across which keratinocytes 
must migrate during wound repair. Therefore, we hypoth- 
esized that this integrin might be critical for normal cuta- 
neous wound healing. However, when either incisional or 
excisional  wounds (2  or 4  mm in diameter  punch biopsy 
wounds) were made in the backs or necks of/36  -t- or/36 +I+ 
mice,  the rate  of healing  and the morphology of healing 
wounds was similar in both groups for mice examined 2, 4, 6, 
or  12  d  after  wounding.  In  both  groups,  all  incisional 
wounds  were  completely  healed  by  day  6,  and  all  exci- 
sional wounds were healed by day 12. These data indicate 
that etv136 is not required for normal wound healing. This 
result could be explained by the expression of other kera- 
tinocyte fibronectin and tenascin receptors.  For example, 
the fibronectin receptor, a5131, was found to be increased 
at the wound edge in both 136  -/- and ~6  ÷/+ mice, and the 
tenascin receptor, et9131 (Palmer et al.,  1993; Yokosaki et 
al.,  1994),  was  constitutively  expressed  on  keratinocytes 
from both types of mice (data not shown). 
f16  -/- Mice Demonstrate Infiltration of the Conducting 
Airways of the Lung by Activated Lymphocytes 
The other significant pathologic finding observed in 136  -/- 
mice  was  in  the  lungs.  Lung morphology was normal  in 
mice examined up to 13 d after birth. However, beginning 
at ~21 d,/36 -t- mice developed infiltration of the walls of 
the  conducting  airways  with  mononuclear  cells  (Fig.  4). 
These  cells  morphologically  resembled  lymphocytes.  In 
contrast to the skin lesions, the lung lesions did not contain 
increased numbers of F4/80 +  cells, but did contain a mix- 
ture of cells that stained with the B  cell marker, B220, or 
the T  cell marker CD3  (data not shown). This pathology 
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power  photomicrograph  of H 
and E stained frozen section of 
a  conducting  airway  from  a 
/36  +/+ (A)  and a /36  -/- mouse 
(B)  demonstrate  accumula- 
tion of mononuclear  cells (ar- 
rowheads) diffusely around  a 
large conducting airway in the 
/36  -/-  mouse.  This  pathology 
was seen in all 11 /36 -/- mice 
examined,  but  in  none  of 16 
/36 +/-  or  /36 +/+  mice.  (C) 
Higher  power  photomicro- 
graph  of  the  same  airway 
shown in B. 
was seen in all 11/36  -/- mice analyzed after 21 d of age. No 
similar lesions were observed in  16/36 +/+ or/36  +/- mice. 
Flow cytometry of cells  obtained from minced lungs dem- 
onstrated  approximately  threefold  increases  in  the  per- 
centages of B cells and CD4+ and CD8+ T cells in/36 -/- 
mice. These mice also demonstrated a marked increase in 
the number of CD4+ T cells that expressed the activation 
marker CD25  (Fig.  5).  These abnormalities in lung mor- 
phology and cellularity were not likely to be due to lung 
infection, since all animals were housed together in a bar- 
rier  facility.  Sentinel  mice  were  examined  weekly  and 
found to be free of specific pathogenic viruses. 
86  -/- Mice Demonstrate Increased 
Airway Responsiveness 
Despite the progressive abnormalities in lung morphology 
noted  in  the  /36 -/-  mice,  these  mice  appeared  healthy, 
without noticeable respiratory distress. However, because 
activated T cells have been implicated in the development 
of asthma  (Gavett et  al.,  1994),  we sought to determine 
whether these animals would demonstrate one of the hall- 
mark features  of asthma,  airway hyperresponsiveness to 
bronchoconstrictor agents such as acetylcholine (Boushey 
et al.,  1980).  Groups of/36  -/- and/36 +/+ mice were anes- 
thetized, tracheostomized, and ventilated in a whole body 
plethysmograph, and pulmonary resistance (RL) was mea- 
sured at baseline and after intravenous administration of 
increasing  concentrations  of acetylcholine.  Baseline  RL 
was the same in both groups of mice (Fig.  6).  The/36  +/+ 
mice developed only small increases in RL, even after ad- 
ministration of the highest concentrations of acetylcholine 
used,  whereas  the  /36 -/-  mice  demonstrated  markedly 
larger responses to each of the two highest concentrations 
(P <  0.001). 
Cells Obtained from the Lungs of 86  -I- Mice 
Express the Th2-associated Cytokine IL-4, but Not 
the Th  rassociated Cytokine lnterferon-~ 
In the most widely studied experimental model of asthma, 
antigen-induced  airway  hyperresponsiveness,  increased 
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Figure 5.  Lymphocyte subsets  in mouse lungs.  Lung cells were 
obtained by mincing lungs pooled from groups of/36  +/+ (open 
bars) and/36 -/  mice (shaded bars). Cells were stained with anti- 
bodies specific for mouse B cells (B220), or T cell markers CD4 
or CD8, and analyzed by flow cytometry. To identify activated 
CD4+ T cells, cells were simultaneously stained with antibodies 
to CD4 and to the lymphocyte activation antigen CD25. 
airway responses to acetylcholine are associated with the 
presence of T  cells in the airway wall that express the so- 
called Th2 (T helper  2)  phenotype,  characterized  by ex- 
pression  of the  cytokines interleukin-4  (IL-4), IL-5, and 
IL-10. In contrast, Thl  ceils, thought to be important for 
cytotoxic  T  cell  responses,  express  the  cytokine  Inter- 
feron--/(IFN--/), but not IL-4, IL-5, or IL-10. Recent data 
using antibodies against IL-4 and IL-4 knockout mice, sug- 
gest that IL-4, in particular,  is crucial to the development 
i 
"I" 
E  ¢j 
v 
-1 
re 
2 
O  i 
B.L 
=  +  T 
---o-- +/+  *_~T 
of airway hyperresponsiveness in this model (Brusselle  et 
al.,  1995;  Corry et  al.,  1996).  To  determine  whether  the 
lymphocytes in the lungs of/76 -/- mice were expressing ei- 
ther Thl or Th2 cytokines, we performed Elispot assays to 
detect  IL-4 or IFN-~/ secretion  from cells  obtained  from 
minced lungs of 136  -/- or/36 +/+ mice. These assays, which 
allow us to count individual lung cells secreting each cyto- 
kine,  demonstrated  a  fourfold increase  in the percentage 
of lung cells that secrete IL-4 with no increase in the per- 
centage of cells that secrete IFN-~/ in /36 -/- mice (Fig. 7). 
Discussion 
Multiple  members of the integrin family are expressed  in 
vivo in epithelial cells, including a2~31, et3131, a9131, et6134, 
etv~35, and etv136. Of these, a6134 is a critical component of 
the hemidesmosomes that basal epithelial cells use for at- 
tachment to the underlying basement membrane,  but the 
functions each of the other integrins play in epithelial tis- 
sues  remain  largely  unknown,  o~vl36 is  the  only  known 
member of the integrin family that is restricted in its distri- 
bution to epithelial cells. However, unlike most epithelial 
integrins,  av136  is  not constitutively expressed  in healthy 
epithelia,  but  is  rapidly  and  transiently  induced  in  re- 
sponse  to  local  injury  or  inflammation.  The  principal 
ligands  identified  for oLv136, fibronectin  and  tenascin,  are 
also absent from healthy epithelia, but present in most in- 
jured and inflamed epithelia. Based on these observations, 
we  and  others  hypothesized  that  otv~6 might  play  some 
critical role in the repair of injured epithelial  tissues.  Be- 
cause of the known in vitro roles played by integrins in cell 
spreading, migration and proliferation,  we presumed that 
any in vivo role of av136  would probably involve one or 
more of these functions. Such effects of etv136 would also 
be consistent  with the  induction  of av136  during  organo- 
genesis,  its  high  level  expression  in  secretory  phase  en- 
dometrium, and its expression in tumors derived from epi- 
thelia;  since  cell  migration,  spreading,  and  proliferation 
are important in organ development, endometrial regener- 
ation, and tumorigenesis. 
The results of the present study are therefore somewhat 
surprising.  /36 -/-  mice  develop  and  reproduce  normally, 
and  are  fully capable  of healing  cutaneous  wounds.  Al- 
though these  observations  by no means prove  that ave6 
1.0  3.0  10  30 
Ach dose (~g/g) 
CD 
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Figure 6.  Airway responsiveness  to acetylcholine in /36 +/+  and 
/36  -/- mice. Total pulmonary resistance (RL) was measured in a 
whole body plethysmograph in seven /36 +/+ mice (open  circles) 
and in six /36 -/- mice (closed squares) from matched litters,  at 
baseline  (B.L.)  and after the administration  of successively  in- 
creasing doses of acetylcholine into an indwelling  tail vein cathe- 
ter.  Data are plotted as the mean (-SD). Pulmonary resistance  a. 
was calculated  using  an  analogue  computer  (model  6,  Buxco, 
Sharon, CT) (22) in mice that were anesthetized, paralyzed, and 
ventilated breathing 100% oxygen with a rodent ventilator (Har- 
vard-Ealing, Millis, MA) at a rate of 150 breaths/min and a tidal 
volume of 9 Ixl/g, settings that resulted in normal arterial blood 
gases  in pilot experiments.  *P <  0.0001 as determined by Stu- 
dent's t test for unpaired data, adjusted for multiple comparisons. 
•  4- 
IL-4  IFN-y 
Figure 7.  Cytokine production by lung cells. Purified lung cells 
were assessed for secretion of IL-4 and IFN-',/using an Elispot as- 
say to detect cytokine secretion from individual  cells. Data are 
expressed as the mean (_+ SD) number of positive spots/106 cells. 
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tion, and/or wound healing, they do suggest that other re- 
ceptors can serve the same functions. However, our obser- 
vation  that  136  -/-  mice  all  develop  inflammatory  cell 
infiltrates in the skin and lungs suggest a previously unex- 
pected role for this integrin in modulating inflammation in 
these epithelial organs. 
It is unclear why the pathology seen in [36 -/- mice has 
thus far been confined to the lungs and skin. In addition to 
these two organs, av[~6 can be expressed on epithelial cells 
in a variety of other organs, including the kidney, uterus, 
testes, ovary, salivary glands, and gall bladder (Breuss et 
al.,  1993). At least in the kidney, as in the lung and skin, 
av136 expression is dramatically upregulated by injury or 
inflammation. In the present study, the mice we describe 
were housed continuously in  a  specific pathogenic virus 
free barrier facility, so they were largely protected from 
environmental insults.  However, the conducting airways 
of healthy mammals are repeatedly exposed to aspirated 
gastric contents, and we hypothesize that focal areas of in- 
jury or inflammation might be routine events, even in ani- 
mals maintained in an environmentally controlled barrier 
facility. In addition, even in a barrier facility, mice are po- 
tentially exposed to inhaled antigens from their food and 
bedding. Similarly, the pattern of abnormality seen in the 
skin of/36  -/- mice might be explained by repeated low- 
level injury. Baldness and macrophage infiltration of the 
skin was most prominent in the head and neck skin of mice 
that had not yet been weaned, and resolved by ~30 d of 
age. This pattern corresponds to the area used by mothers 
to lift and move mouse pups. The inside of the thighs is 
also an area that could be subjected to continuous low- 
level irritation.  In  this  region,  hair  loss  persists  even in 
adult/36 -/- mice. 
One  explanation for our findings is  that c~vl36 partici- 
pates in the regulation of local factors that are responsible 
for activation, recruitment and/or proliferation of lympho- 
cytes and/or monocytes. For example, expression of av136 
following epithelial injury could modulate the synthesis of 
inflammatory cytokines by epithelial cells, contributing to 
the termination of the local inflammatory response. Inacti- 
vation of c~vl36, especially in sites such as the airways and 
skin  that  are  repeatedly  exposed  to  injurious  stimuli, 
would thus lead to persistent inflammation. A  role for in- 
tegrins in regulation of cytokine gene expression has been 
demonstrated in mononuclear cells, where the regulation 
of expression of several cytokine genes can be dramati- 
cally altered by plating cells on different extracellular ma- 
trix  substrates,  an  effect  that  is  mediated  by  integrins 
(Haskill et al., 1988; Juliano and Haskill, 1993; Miyake et 
al.,  1993).  It  is  now well-recognized that  epithelial  cell- 
derived chemokines and  other cytokines play important 
roles in initiating and modulating inflammatory responses 
in epithelial organs, including the lungs and skin (Becker 
et al., 1994; Bellini et al., 1993; DiCosmo et al., 1994; Elias et 
al., 1994; Sousa et al., 1994). For example, one of the cyto- 
kines synthesized by airway epithelial cells, IL-6, induces 
the  proliferation of both B  lymphocytes and T  lympho- 
cytes, and also induces lymphocyte activation, as detected 
by expression of the interleukin-2 receptor, CD-25 (Lotz 
et al.,  1988; Tosato et al.,  1988; Tosato and Pike,  1988). 
Overexpression of IL-6 in the airway epithelium of trans- 
genic mice induced a very similar pathology to that seen in 
the/36  -/- mice we describe, including large accumulations of 
B cells and T cells adjacent to conducting airways (DiCosmo 
et al., 1994). 
One surprising feature of our results is that the charac- 
ter of the inflammatory ceils in the skin and lungs of/36  -/- 
mice is different. The cells in the skin are principally macro- 
phages, whereas the cells in the lung are principally B and T 
lymphocytes. This difference suggests that either the ef- 
fects of ~v~6 ligation on keratinocytes and airway epithe- 
lial cells are different, or that the subsequent cellular re- 
sponses to any effects of avt36 ligation are different in the 
microenvironments of the skin and lungs. Differential ef- 
fects of cytokines in different tissues are well described. 
For example, transgenic mice overexpressing interleukin-6 
in airway epithelial cells develop loci of lymphocytes sur- 
rounding conducting airways in a pattern quite similar to 
that seen in the ~6  -/- mice we describe (DiCosmo et al., 
1994). However, mice overexpressing IL-6 in keratinocytes 
do not develop lymphocytic infiltrates in the skin (Turksen 
et al., 1992). 
The /36  -/-  mice we describe demonstrate dramatic in- 
creases in bronchomotor responsiveness to acetylcholine, 
the hallmark feature of asthma in humans (Boushey et al., 
1980). Lymphocytes are thought to play an important role 
in  induction  of  airway  hyperresponsiveness  in  human 
asthma (Robinson et al., 1992; Walker et al., 1991) and are 
the  principal  cell type recruited to the  airways in these 
mice. Furthermore, as in human asthma, the CD4+ T cells 
in the  airways of 136  -/- mice appear to be activated. Fi- 
nally, the lungs of ~6  -/- mice contain many more IL-4 se- 
creting cells than do the lungs of 136 +/+ mice. Two recent 
studies  in  which  airway  hyperresponsiveness  was  tran- 
siently induced in ovalbumin-sensitized mice by inhalation 
of ovalbumin suggested that IL-4 played an important role 
in the induction of airway hyperresponsiveness. In one of 
these studies, IL-4 deficient mice were shown to be resis- 
tant  to  ovalbumin-induced  airway  hyperresponsiveness 
(Brusselle et al., 1995), and in the other study, ovalbumin- 
induced airway hyperresponsiveness was prevented by ad- 
ministration of an anti-IL-4 antibody (Corry et al., 1996). 
One  feature  that  distinguishes  the  animals  we  describe 
from most people with asthma, and from ovalbumin-sensi- 
tized and challenged animals is the absence of eosinophils 
in the airways. Despite the absence of eosinophils,/36  -/- 
mice  demonstrated  marked  airway  hyperresponsiveness, 
suggesting that eosinophils are not required for induction 
of this physiologic abnormality. These data are consistent 
with the recent report that treatment of ovalbumin-sensi- 
tized  and  challenged mice with  anti-IL-5  antibody pre- 
vents airway eosinophilia but has no effect on the induc- 
tion of airway hyperresponsiveness. 
As discussed above, in the most widely studied experi- 
mental models of asthma, lymphocytes are recruited to the 
airways and activated in response to inhalation of specific 
allergens (Gavett et al., 1994). These models suffer from a 
high degree of variability and from the transient nature of 
the airway hyperresponsiveness induced. Moreover, many 
patients with asthma are not atopic, and most clinical exac- 
erbations  of  asthma  are  provoked  by  nonimmunologic 
stimuli (Boushey et al., 1980). Many of these stimuli, in- 
cluding viral infection and inhalation of irritant gases, are 
Huang et al. Integrin  86 Subunit Knockout  927 likely  to  directly  affect  the  airway  epithelium.  Further- 
more, one nearly universal feature of human asthma is an 
alteration in the amount and composition of extracellular 
matrix in the airway wall (Djukankovic et al., 1990; James 
et al., 1989; Laitinen and Laitinen, 1994). The results of the 
present study suggest that these changes in the matrix, de- 
tected by integrins, could modulate recruitment and acti- 
vation of airway lymphocytes, and that genetic or environ- 
mental inactivation of the airway epithelial integrin, c~vl36, 
could induce or potentiate the airway lymphocytosis  and 
airway hyperresponsiveness that characterize  human asthma. 
Similarly, alterations in signals initiated through epithelial 
integrins could contribute to inflammatory diseases affect- 
ing other epithelial organs. 
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